CLPTM1L is a GPI-anchoring pathway component targeted by HCMV

Inbal Kol1, Ahmed Rishiq1, Mevaseret Cohen1

  • 1The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah-Hebrew University Medical Center , Jerusalem, Israel.

PubMed